Related Experiment Video
Updated: Jun 3, 2025
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Primary and secondary cardiovascular prevention: Recent advances
Maciej Banach1,2,3,4, Peter P Toth5,6, Agata Bielecka-Dąbrowa7,8
1Faculty of Medicine, The John Paul II Catholic University of Lublin, Lublin, Poland. maciej.banach@kul.pl.
Insights
Cardiovascular disease (CVD) prevention is evolving beyond traditional age and time limits. Focusing on atherosclerosis as a continuous process with new treatments and digital tools can improve outcomes.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Cardiovascular disease (CVD) is a major global health issue, causing 20 million deaths annually.
- Current risk prediction models may be limited by focusing solely on individuals over 40 and short-term (10-year) predictions.
- The distinction between primary and secondary prevention warrants re-evaluation, considering atherosclerosis as a continuous process.
Purpose of the Study:
- To review the latest advancements in cardiovascular disease (CVD) diagnosis and prevention strategies.
- To explore the integration of novel therapeutic agents and digital health tools in CVD management.
- To assess the potential of updated prevention strategies in reducing the global burden of CVD.
Main Methods:
- Literature review of recent developments in CVD prevention.
- Analysis of pharmacological treatments, technological innovations, and lifestyle modifications.
- Examination of novel agents and digital health tools for patient adherence and outcomes.
Main Results:
- Significant advancements in pharmacological treatments and lifestyle interventions (diet, physical activity, sleep, smoking cessation) are crucial for coronary artery disease prevention.
- Novel agents and digital health tools show promise in improving long-term patient adherence and clinical outcomes.
- Integrating these advancements can enhance the effectiveness of both primary and secondary CVD prevention.
Conclusions:
- The evolving landscape of CVD prevention necessitates a broader approach, considering atherosclerosis as a continuous process.
- Novel therapeutic agents and digital health technologies are key to improving patient outcomes and adherence.
- Enhanced integration of these strategies into clinical practice is vital for reducing the global burden of cardiovascular disease.
Abstract:
Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide with 20 million deaths annually. Recent advances in both primary and secondary prevention strategies have shown promising results in reducing the incidence and recurrence of cardiovascular events, but a question of fundamental importance is whether we are effective enough when predicting risk only in those over 40 years of age and only for 10 years. A similarly important question concerns the pathophysiological border between primary and secondary prevention and whether we should reorient our focus to atherosclerosis prevention as a continuous process that becomes clinically apparent later in life. The landscape of CVD prevention is rapidly evolving, with significant advancements in pharmacological treatments, technological innovations, and such lifestyle modifications as adopting a healthy diet, engaging in regular physical activity (PA), ensuring quality sleep, and quitting smoking, being crucial in the prevention of coronary artery disease. Integrating these strategies into clinical practice can enhance the effectiveness of both primary and secondary prevention, ultimately reducing the global burden of cardiovascular disease. This review highlights the latest developments and strategies aimed at diagnosis and preventing CVD. Key areas of focus include the use of novel agents and the role of digital health tools in improving both long-term patient adherence to evidence-based interventions and outcomes. The integration of these advancements into clinical practice has the potential to significantly enhance cardiovascular health and reduce the global burden of CVD.
More Related Videos
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Preventive Healthcare Services
01:26Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...